Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Addex Therapeutics Q2 EPS $(2.90) Down From $10.61 YoY

Author: Benzinga Newsdesk | September 30, 2025 12:22am
Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(2.90) per share. This is a 127.37 percent decrease over earnings of $10.61 per share from the same period last year.

Posted In: ADXN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist